Empagliflozin impurity 30 CAS 2262435-19-6

Description

Compared with other compounds in its class, the molecular weight of 635.06 g/mol gives Empagliflozin impurity 30 distinctive chromatographic separation conditions and mass-spectrometry parameter settings.

CATO supplies Empagliflozin impurity 30 (CAS 2262435-19-6), a pharmacopoeial impurity reference standard (molecular formula C31H35ClO12, MW 635.06 g/mol) used for the identification and quantification of trace impurities in APIs.

Empagliflozin impurity 30 (C31H35ClO12) contains a carboxylic acid group, a hydroxyl group, an ether linkage, chlorine substitution, a polycyclic aromatic system. Halogen substitution raises its density and boiling point, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

CATO manufactures Empagliflozin impurity 30 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com